Clinical Trials Logo

Ischemic Cardiomyopathy clinical trials

View clinical trials related to Ischemic Cardiomyopathy.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01825239 Withdrawn - Cardiomyopathy Clinical Trials

Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy

Start date: April 2014
Phase: N/A
Study type: Interventional

Presently, the left ventricular lead is placed in a similar position for all patients. It is not known whether placing this lead in different positions in the heart will make the heart pump better. In this study, the investigator will collect measurements of the heart's electrical activity during an Electrophysiology Study (EP study or EPS). The hope is that these measurements will provide the know how to develop an individualized left ventricular lead placement "prescription" for patients referred for left ventricular lead pacing.

NCT ID: NCT01496209 Withdrawn - Clinical trials for Ischemic Cardiomyopathy

REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts

RECONSTRUCT
Start date: July 2015
Phase: Phase 1
Study type: Interventional

A double blinded and placebo-controlled, dose escalation, single-center safety and preliminary efficacy study of cardiospheres delivered via NOGA MYOSTAR injection catheter in subjects with chronic ischemic cardiomyopathy. The objective is to achieve and document myocardial regeneration in patients with chronic scar.

NCT ID: NCT00326690 Withdrawn - Clinical trials for Coronary Artery Disease

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Start date: November 2005
Phase: N/A
Study type: Interventional

The purpose of the present prospective, randomized study is to investigate the clinical effectiveness of standardized left ventricular reconstruction surgery (LVR). In order to standardize the procedure, the operation will be performed with the Blue Egg, manufactured by BioVentrix, a subsidiary of CHF Technologies, Inc.